Skip to main content

Xponance, Inc.

SEC CIK
0001637541
Latest filing
Aug 10, 2026

ABT holding history

Abbott Laboratories in every 13F filed by Xponance, Inc., including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

ABT overviewAll 13F holders of ABTFull Q2 2026 holdings

Shares (Q2 2026)
314,309
Value
$28.5M
% of portfolio
0.2%
Quarters held
22
Since Q1 2021
Holdings of ABT by Xponance, Inc., by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 2026314,309$28.5M0.2%+522+0.2%AddedHolders
Q1 2026313,787$32.2M0.2%+39,547+14.4%AddedHolders
Q4 2025274,240$34.4M0.3%+15,650+6.1%AddedHolders
Q3 2025258,590$34.6M0.3%−31,276−10.8%ReducedHolders
Q2 2025289,866$39.4M0.3%+15,577+5.7%AddedHolders
Q1 2025274,289$36.4M0.4%+5,637+2.1%AddedHolders
Q4 2024268,652$30.4M0.3%+26,192+10.8%AddedHolders
Q3 2024242,460$27.6M0.3%+2,949+1.2%AddedHolders
Q2 2024239,511$24.9M0.3%−11,115−4.4%ReducedHolders
Q1 2024250,626$28.5M0.3%+14,720+6.2%AddedHolders
Q4 2023235,906$26.0M0.3%+17,809+8.2%AddedHolders
Q3 2023218,097$21.1M0.3%+3,702+1.7%AddedHolders
Q2 2023214,395$23.4M0.3%−19,755−8.4%ReducedHolders
Q1 2023234,150$23.7M0.3%−1,701−0.7%ReducedHolders
Q4 2022235,851$25.9M0.4%+33,815+16.7%AddedHolders
Q3 2022202,036$19.5M0.4%+25,286+14.3%AddedHolders
Q2 2022176,750$19.2M0.4%−55,417−23.9%ReducedHolders
Q1 2022232,167$27.5M0.5%+29,433+14.5%AddedHolders
Q4 2021202,734$28.5M0.4%+24,648+13.8%AddedHolders
Q3 2021178,086$21.0M0.4%−22,843−11.4%ReducedHolders
Q2 2021200,929$23.3M0.4%−6,517−3.1%ReducedHolders
Q1 2021207,446$24.9M0.5%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.